Conference Chair

    profile Photo

    Professor of Medicine | Conference Chair

    Reichman University ,Herzelia, Israel,

    Zabludowicz Center for Autoimmune Diseases (Founder),
    Sheba Medical Center

    About Conference

    Dear Participants, Distinguished Speakers, and Scholars,

    Welcome to the Global Summit on Vaccines and Immunology (GSVIM2024) in the vibrant city of Barcelona, Spain, from October 17-19, 2024!

    As we gather for this prestigious event, I extend a warm invitation to Vaccines and Immunology experts to join us in shaping the future of our field. Chaired by the esteemed Prof. Yehuda Shoenfeld.

    This is your opportunity to share innovative ideas, connect with leading minds, and contribute to the ongoing advancements in Vaccines and Immunology. Our event features a lineup of plenary, keynote, and invited presentations by distinguished international experts who will share their world-class scientific research and development.

    We are proud to be at the forefront of this dynamic and rapidly evolving field, where advancements are driven by unwavering dedication, collaboration, and continuous innovation.

    To all participants, your voice is crucial in influencing the future of Vaccines and Immunology. Register today for this exclusive event and be part of the change.

    We eagerly anticipate your insightful contributions and look forward to your valuable presence at GSVIM2024.

    Best Regards,

    Professor of Medicine | Conference Chair

    Reichman University ,Herzelia, Israel,

    Zabludowicz Center for Autoimmune Diseases (Founder),
    Sheba Medical Center
    Tel-Hashomer 5265601, Israel

    Apex Global Meetings | GSVIM2024


    Advances in Antimicrobials, Vaccines & Therapeutics

    Agricultural Microbiology

    Animal Modeling and Veterinary Microbiology

    Antimicrobial Agents and Infectious Diseases

    Antiviral, Antibacterial, Antimicrobial Agents

    Bloodstream Infections and Infective Endocarditis

    Central Nervous System Infections

    COVID-19 and Pharmaceutical Microbiology

    Current Trends in Microbiology

    Diagnostic Microbiology and its Application

    Diseases, Diagnosis And Treatment of Microbial Infections

    Epidemiology of Infectious Diseases and Public Health Concerns

    Gastrointestinal Infection

    Immunization and Allergies

    Immunization and Mental Health

    Immunization and the Role of Artificial Intelligence

    Immunization and Travel Medicine

    Immunization Ethics and Equity

    Immunization in Pregnancy

    Immunization in the Elderly Population

    Immunization in the Era of Genomic Medicine

    Immunization Strategies for Pediatrics

    Immunology in Animals, Plants and Human beings

    Immunology of Infectious Diseases


    Immunotherapy for Cancer: Current Status and Prospects

    Infection, Immunity And Inflammation

    Innovations in Vaccine Delivery Systems

    Innovations in Vaccine Storage and Cold Chain Management

    Management of Diagnostic Microbiology Laboratory

    Microbial Genomics And Molecular Microbiology

    Microbiome and Immunity

    Mucosal Immunology and Vaccines

    Pathogenicity of Microbes

    Public Health Microbiology And Emerging Infectious Diseases

    Regulatory Affairs in Vaccine Development

    Sexually Transmitted Infections

    Types Of Infectious Diseases

    Vaccination Programs in Low-Resource Settings

    Vaccine Adjuvants and Formulations

    Vaccine Development for Emerging Viruses

    Vaccine Diplomacy and Global Health Partnerships

    Vaccine Education and Advocacy

    Vaccine Hesitancy in a Global Context

    Vaccine Manufacturing and Quality Control

    Vaccine Safety Monitoring and Surveillance

    Vaccines and Antibiotic Resistance

    Vaccines for Autoimmune Diseases

    Vaccines for Biodefense and Bioterrorism

    Vaccines for Emerging Infections in Aquatic Animals

    Vaccines for Neglected Tropical Diseases

    Vector-Borne Diseases and Vaccine Development

    Zoonotic Diseases and Cross-Species Vaccination

    The vaccines and immunology market is a dynamic and critical segment within the global healthcare industry. It encompasses a wide range of products and services aimed at preventing, diagnosing, and treating infectious diseases and disorders of the immune system. Over the years, this market has witnessed significant growth and transformation driven by factors such as increasing awareness of vaccination, expanding research and development efforts, and the emergence of novel vaccine technologies.

    One of the primary drivers of this market is the growing emphasis on disease prevention and public health. Vaccines are considered one of the most cost-effective ways to prevent infectious diseases, and governments, as well as healthcare organizations, have been actively promoting immunization programs. Moreover, the COVID-19 pandemic has further underscored the importance of vaccines in combating global health crises, leading to accelerated research, development, and distribution efforts.

    Innovation and technological advancements have played a pivotal role in shaping the vaccines and immunology landscape. The introduction of mRNA vaccine platforms, for instance, has revolutionized vaccine development and has demonstrated unprecedented efficacy during the COVID-19 pandemic. Additionally, advancements in vaccine delivery systems, adjuvants, and formulations continue to enhance vaccine safety and efficacy profiles.

    The vaccines and immunology market is also witnessing expansion beyond infectious diseases. Vaccines are increasingly being explored as potential therapies for non-communicable diseases like cancer and autoimmune disorders. This diversification of vaccine applications has opened up new avenues for research and investment.

    However, challenges persist within this market, including vaccine hesitancy, supply chain complexities, and the need for robust regulatory oversight. Addressing these challenges is crucial to ensuring the successful development, distribution, and adoption of vaccines.

    As the world continues to grapple with infectious diseases and seeks innovative solutions for global health challenges, the vaccines and immunology market is poised for sustained growth. Collaboration among governments, research institutions, pharmaceutical companies, and healthcare providers will be essential to drive innovation, improve access to vaccines, and ultimately improve public health outcomes.


    Important Dates

    Abstract Submission Deadline

    August 01, 2024

    Earlybird Registration Deadline

    February 28, 2024

    Standard Registration Deadline

    March 25, 2024

    Onspot Registration

    October 17, 2024

    Scientific Committee

    Volen Atim

    Prof. Michael Bukrinsky

    The George Washington University
    Volen Atim

    Prof. Luisa Maria Arvide Cambra

    University of Almeria
    Volen Atim

    Dr. Stefan Bittmann

    Ped Mind Institute
    Volen Atim

    Dr. Luca Roncati,

    University of Modena and Reggio Emilia

    Plenary Speakers

    Prof. Yehuda Shoenfeld

    Department of Zabludowicz Center for Autoimmune Diseases
    Tel-Aviv University
    H-index 167

    Prof. Michal Schwartz's

    Professor of Neuroimmunology Weizmann Institute of Science
    H-Index 121

    Associate director Lisa E Hensley

    Associate Director. US Army Medical Research Institute
    H-Index 88

    Prof. Tomas Hanke

    University of Oxford and a Distinguished Professor, Kumamoto University
    H-Index 67

    Dr. Pietro Mastroeni

    Department of Veterinary Medicine at the University of Cambridge
    H-Index 57
    United Kingdom

    Prof. Deepak Kaushal

    Department of Microbiology, Immunology and Molecular Genetics
    Director of the Southwest National Primate Research Center
    H-Index 56

    Dr. Raymond Goodrich

    Director of the I(IDRC), Colorado State University
    H-Index 52

    Invited Speakers

    Dr. Nir Ben Chetrit

    Research Associate in Medicine
    Weill Cornell Medical College
    The New York Genome Center

    Assoc Prof. Elizabeth Norton

    Department of Microbiology and Immunology
    Tulane University

    Assoc Prof. Zhang Xiao

    School of Pharmacy
    Chongqing Medical University

    Mr. Guillaume Mwamba

    Senior Program Manager chez VillageReach
    Karolinska Institute
    DR Congo

    Mr. Ouedraogo Hamed Sidwaya

    Head of the Department of Population Health Protection at the Ministry of Health of Burkina Faso
    Burkina Faso

    Featured Speakers

    Dr. Nawal Mohammed Helmi

    Department of Infection, Immunity and Inflammation
    University of Jeddah
    Saudi Arabia

    Media Partners


    Registration Includes

    • Access to all conference sessions, poster and exhibition area
    • Conference kit including name tag, program booklet and Abstracts book
    • 2 Coffee breaks and lunch for all the event days of the conference
    • Certificate of participation from Conference chair/ Session chair
    • Access to the all scientific sessions
    • Access to Business Development Sessions and Global Networking Session

    Benefits of Joining Conference

    • Encouraged to publish full length articles in Supporting Journals with discounted APC charges
    • Best Oral, Poster and Young Research Forum (YRF) presentation awards
    • Get Opportunity to Collaborate with future Apex Global Meetings
    • Avail Group Booking Discounts

    Group Booking Discounts

    Groups of three or more will receive a Special discount by using the group code. If you have any queries, please contact us at or call